Search results
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 22 hours agoDespite a bevy of promising updates for its cancer treatments, Pfizer stock remained trapped below a...
Sarepta Jumps on Broad Approval for Muscular Dystrophy Drug
Bloomberg via Yahoo Finance· 2 hours ago(Bloomberg) -- Sarepta Therapeutics Inc.’s gene therapy received expanded US approval to include...
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
The Motley Fool via AOL· 3 days agoWhen it comes to investing in high-yield dividend stocks in the pharmaceutical space, two prominent...
Pfizer (NYSE:PFE) Trading 1.3% Higher
ETF DAILY NEWS· 1 day agoPfizer Inc. (NYSE:PFE – Get Free Report) traded up 1.3% on Tuesday . The company traded as high as $27.38 and last traded at $27.32. 8,155,528 shares changed hands during ...
Kansas AG Kris Kobach suing Pfizer for ‘misleading Kansans on COVID vaccine’
KWCH· 4 days agoKansas Attorney General Kris Kobach announced that he’s suing Pfizer “for misleading claims it made...
Kobach sues Pfizer over COVID vaccine claims
KSNW Wichita via Yahoo News· 4 days agoKansas Attorney General Kris Kobach has filed a lawsuit against Pfizer. He says the company made misleading and deceptive claims about its COVID-19...
Kansas sues Pfizer over COVID vaccine for what Kris Kobach calls 'misleading marketing'
The Topeka Capital-Journal via Yahoo News· 4 days agoKansas Attorney General Kris Kobach is suing Pfizer over its COVID-19 vaccine, alleging the company...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks· 10 hours agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Pfizer</ ...
Gilead (GILD) Up as Twice-Yearly HIV Shot Prevents Infection
Zacks via Yahoo Finance· 2 hours agoGilead's (GILD) twice-yearly, subcutaneous lenacapavir has demonstrated its potential as a new tool...
Analysts Set Pfizer Inc. (NYSE:PFE) Price Target at $35.86
ETF DAILY NEWS· 2 days agoPfizer Inc. (NYSE:PFE – Get Free Report) has been assigned an average rating of “Hold” from the fifteen ratings firms that are currently covering the stock, MarketBeat Ratings ...